Black Titan Corporation Ordinary Shares (BTTC)
Stock · NASDAQ · Health Care
$0.4334as of 8/28/2026
Price chart
Open in TradingViewActive signals
High Beta88.3%
Resistance level
$0.757719
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
How Black Titan Corporation Ordinary Shares Makes Money
Where the revenue actually goes — FY2023 annual results
Source: 10-K filed Apr 1, 2024 · via SEC EDGAR / Finnhub
Black Titan Corporation Ordinary Shares Competitors
Chosen by industry and closest market cap.
- BTTCBlack Titan Corporation Ordinary Shares$0.4334▼ 7.98%Market cap $1.02MP/E —
- SCNIScinai Immunotherapeutics Ltd. American Depositary Shares$2.53▼ 5.60%Market cap $1.30MP/E 0.14$2.15$16.8
- PHGEBiomX Inc. COmmon Stock$0.138▲ 4.55%Market cap $3.95MP/E —$0.1192$12.29
- VIVSVivoSim Labs Inc. Common Stock$0.29▲ 0.00%Market cap $5.53MP/E —$0.2625$5.3
- AIMAIM ImmunoTech Inc. Common Stock$0.2558▲ 2.32%Market cap $7.51MP/E —$0.1901$2.89
- CRISCuris Inc. Common Stock$1.49▲ 2.76%Market cap $8.59MP/E —$1.4$39
- BCDABioCardia Inc. Common Stock$1.16▼ 0.85%Market cap $10.80MP/E —$0.75$2.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BTTC Black Titan Corporation Ordinary Shares | $1.02M | — | $0.4334 | ▼ 7.98% | |
| SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares | $1.30M | 0.14 | $2.53 | ▼ 5.60% | $2.15$16.8 |
| PHGE BiomX Inc. COmmon Stock | $3.95M | — | $0.138 | ▲ 4.55% | $0.1192$12.29 |
| VIVS VivoSim Labs Inc. Common Stock | $5.53M | — | $0.29 | ▲ 0.00% | $0.2625$5.3 |
| AIM AIM ImmunoTech Inc. Common Stock | $7.51M | — | $0.2558 | ▲ 2.32% | $0.1901$2.89 |
| CRIS Curis Inc. Common Stock | $8.59M | — | $1.49 | ▲ 2.76% | $1.4$39 |
| BCDA BioCardia Inc. Common Stock | $10.80M | — | $1.16 | ▼ 0.85% | $0.75$2.29 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.